Months after adding $60M to coffers, AI startup Terray nabs discovery pact with Google's Calico

Paul Schloesser

Associate Editor

A small California biotech emerged from stealth last year to go after drug discovery’s “data problem,” and now the AI outfit has announced its first …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Months after adding $60M to coffers, AI startup Terray nabs discovery pact with Google's Calico

Paul Schloesser

Associate Editor

Sign up to read this article for free.

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

New fund will pressure flailing biotechs, as investor frustration boils over

FDA chief Makary talks expediting drug approvals, RIFs and the abortion pill

Akeso shares new data suggesting it can beat Keytruda on survival, wins China approval

AbbVie commits $10B to expand US footprint with the threat of tariffs ahead

J&J reports durability data for bladder cancer 'pretzel' drug after FDA filing

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

Months af­ter adding $60M to cof­fers, AI start­up Ter­ray nabs dis­cov­ery pact with Google's Cal­i­co

Associate Editor

Sign up to read this article for free.

Gondolabio

Palo Alto, CA, USA

Months after adding $60M to coffers, AI startup Terray nabs discovery pact with Google's Calico